186 related articles for article (PubMed ID: 17698796)
1. Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma.
Kranick SM; Mowry EM; Rosenfeld MR
Neurology; 2007 Aug; 69(7):704-6. PubMed ID: 17698796
[No Abstract] [Full Text] [Related]
2. Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab.
Tuccori M; Focosi D; Maggi F; Cosottini M; Meini B; Lena F; Blandizzi C; Del Tacca M; Petrini M
Ann Hematol; 2010 May; 89(5):519-22. PubMed ID: 19727726
[No Abstract] [Full Text] [Related]
3. Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis.
Fleischmann RM
Arthritis Rheum; 2009 Nov; 60(11):3225-8. PubMed ID: 19877057
[TBL] [Abstract][Full Text] [Related]
4. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
[TBL] [Abstract][Full Text] [Related]
5. [Progressive multifocal leukoencephalopathy after natalizumab therapy].
Schmitt C; Bensussan A
Med Sci (Paris); 2005 Oct; 21(10):797-8. PubMed ID: 16197890
[No Abstract] [Full Text] [Related]
6. Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.
Paues J; Vrethem M
J Clin Virol; 2010 Aug; 48(4):291-3. PubMed ID: 20558102
[TBL] [Abstract][Full Text] [Related]
7. Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy.
Colosimo C; Lebon P; Martelli M; Tumminelli F; Mandelli F
Acta Neurol Belg; 1992; 92(1):24-9. PubMed ID: 1546522
[TBL] [Abstract][Full Text] [Related]
8. Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.
Steurer M; Clausen J; Gotwald T; Gunsilius E; Stockhammer G; Gastl G; Nachbaur D
Transplantation; 2003 Jul; 76(2):435-6. PubMed ID: 12883208
[No Abstract] [Full Text] [Related]
9. Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.
Berger T; Deisenhammer F
N Engl J Med; 2005 Oct; 353(16):1744-6; author reply 1744-6. PubMed ID: 16236749
[No Abstract] [Full Text] [Related]
10. Rituximab in relapsing-remitting multiple sclerosis.
Schrijver HM
N Engl J Med; 2008 Jun; 358(24):2645; author reply 2646-7. PubMed ID: 18557177
[No Abstract] [Full Text] [Related]
11. Natalizumab for relapsing multiple sclerosis.
Jeffery DR
N Engl J Med; 2006 Jun; 354(22):2387-9; author reply 2387-9. PubMed ID: 16742008
[No Abstract] [Full Text] [Related]
12. JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab.
Rey J; Belmecheri N; Bouayed N; Ivanov V; Coso D; Gastaut JA; Bouabdallah R
Haematologica; 2007 Oct; 92(10):e101. PubMed ID: 18024364
[No Abstract] [Full Text] [Related]
13. Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
Tuccori M; Focosi D; Blandizzi C; Del Tacca M; Petrini M
J Natl Cancer Inst; 2009 Sep; 101(18):1288-9; author reply 1289-90. PubMed ID: 19687414
[No Abstract] [Full Text] [Related]
14. PML risk and natalizumab: more questions than answers.
Ransohoff RM
Lancet Neurol; 2010 Mar; 9(3):231-3. PubMed ID: 20117056
[No Abstract] [Full Text] [Related]
15. [Natalizumab in multiple sclerosis].
Rajda C; Bencsik K; Vécsei L;
Ideggyogy Sz; 2008 May; 61(5-6):204-8. PubMed ID: 18567397
[No Abstract] [Full Text] [Related]
16. Selective adhesion-molecule therapy and inflammatory bowel disease.
Chaudhuri A
N Engl J Med; 2006 Feb; 354(6):644-5; author reply 644-5. PubMed ID: 16467556
[No Abstract] [Full Text] [Related]
17. Third Tysabri adverse case hits drug class.
Sheridan C
Nat Rev Drug Discov; 2005 May; 4(5):357-8. PubMed ID: 15902765
[No Abstract] [Full Text] [Related]
18. Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature.
Pelosini M; Focosi D; Rita F; Galimberti S; Caracciolo F; Benedetti E; Papineschi F; Petrini M
Ann Hematol; 2008 May; 87(5):405-12. PubMed ID: 18064459
[TBL] [Abstract][Full Text] [Related]
19. Progressive multifocal leukoencephalopathy in a patient with follicular lymphoma treated with multiple courses of rituximab.
Reddy N; Abel TW; Jagasia M; Morgan D; Weaver K; Greer J
Leuk Lymphoma; 2009 Mar; 50(3):460-2. PubMed ID: 19266387
[No Abstract] [Full Text] [Related]
20. Tysabri raises alarm bells on drug class.
Sheridan C
Nat Biotechnol; 2005 Apr; 23(4):397-8. PubMed ID: 15815649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
